Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1927 1
1929 1
1962 1
1975 1
1976 1
1978 1
1980 1
1982 1
1983 1
1984 1
1985 2
1986 1
1987 3
1988 1
1989 3
1990 3
1991 4
1992 5
1993 4
1994 6
1995 8
1996 4
1997 9
1998 6
1999 5
2000 2
2001 6
2002 3
2003 9
2004 7
2005 6
2006 8
2007 13
2008 5
2009 9
2010 10
2011 13
2012 8
2013 4
2014 7
2015 5
2016 6
2017 15
2018 8
2019 12
2020 21
2021 25
2022 18
2023 24
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T, Katayama Y, Hiasa Y, Nishihara M, Tajima F, Katoh S, Tanaka H, Maeda T, Furusawa K, Richardson M, Kakehi Y, Kikumori K, Kuroha M. Ushida T, et al. Among authors: furusawa k. Neurology. 2023 Mar 14;100(11):e1193-e1206. doi: 10.1212/WNL.0000000000201709. Epub 2022 Dec 14. Neurology. 2023. PMID: 36517235 Free PMC article. Clinical Trial.
Chiral measure of chiral polyhedrons.
Kimura T, Kimura R, Mizukoshi Y, Furusawa K. Kimura T, et al. Among authors: furusawa k. Chirality. 2024 Feb;36(2):e23633. doi: 10.1002/chir.23633. Chirality. 2024. PMID: 38384153
Support for UNRWA's survival.
Blanchet K, El-Zein A, Langer A, Sato M; 159 signatories. Blanchet K, et al. Lancet. 2018 Sep 22;392(10152):1009-1010. doi: 10.1016/S0140-6736(18)32264-5. Epub 2018 Sep 12. Lancet. 2018. PMID: 30219332 Free article. No abstract available.
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
Hayashi K, Furuta M, Furusawa K, Hamaguchi T, Watanabe M, Inokuchi Y, Onuma S, Hashimoto I, Suematsu H, Nagasawa S, Kanematsu K, Yamada T, Notsu A, Ogata T, Oshima T, Machida N, Furuse J, Maeda S. Hayashi K, et al. Among authors: furusawa k. Anticancer Res. 2023 Jun;43(6):2831-2840. doi: 10.21873/anticanres.16452. Anticancer Res. 2023. PMID: 37247885
287 results